Document is current
Any future updates will be listed below
-
Authors
Sabol, Hayley M.
Paxton, Bethany C.
Anloague, Aric
Kaur, Japneet
Nester, Mattie R.
Khan, Sharmin
Smith, James
Croucher, Peter I.
McDonald, Michelle M.
Montgomery, Corey O.
Stambough, Jeffrey B.
Barnes, C. Lowry
Ambrogini, Elena
Ebetino, Frank H.
Schinke, Carolina
Ashby, Cody
Delgado-Calle, Jesús https://orcid.org/0000-0002-2083-2774
-
Funding
Funding for this research was provided by:
National Institutes of Health (F31CA284655)
National Institutes of Health (P20GM125503)
National Institutes of Health (KL2TR003108)
National Institutes of Health (R37CA251763)
- License Information
-
More Information
Article History
Received: 26 August 2025
Accepted: 26 December 2025
First Online: 5 January 2026
Declarations
:
: All procedures involving animals were performed in accordance with guidelines issued by the University of Arkansas for Medical Sciences IACUC (protocol #2022200000489). Collection and de-identification of human bone samples for ex vivo studies were coordinated by the UAMS Winthrop P. Rockefeller Cancer Institute TBAPS and approved by the UAMS IRB (protocol # 262940). Deidentified primary CD138+ cells were obtained from MM patients during clinic visits at the University of Arkansas for Medical Sciences. Signed Institutional Review Board–approved informed consent forms are kept on record at the University of Arkansas for Medical Sciences Tissue Biorepository and Procurement Service (TBAPS) under approved protocols IRB 262254 and 260887.
: Not applicable.
: The authors declare no competing interests.
